CH429739A - Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten - Google Patents
Verfahren zur Herstellung von basisch substituierten AlkylxanthinderivatenInfo
- Publication number
- CH429739A CH429739A CH54863A CH54863A CH429739A CH 429739 A CH429739 A CH 429739A CH 54863 A CH54863 A CH 54863A CH 54863 A CH54863 A CH 54863A CH 429739 A CH429739 A CH 429739A
- Authority
- CH
- Switzerland
- Prior art keywords
- alkylxanthine
- derivatives
- preparation
- basic substituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DED38531A DE1221641B (de) | 1962-03-30 | 1962-03-30 | Verfahren zur Herstellung von basisch substituierten Theophyllinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH429739A true CH429739A (de) | 1967-02-15 |
Family
ID=7044170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH54863A CH429739A (de) | 1962-03-30 | 1963-01-17 | Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE630294A (de) |
| BR (1) | BR6347019D0 (de) |
| CH (1) | CH429739A (de) |
| DE (1) | DE1221641B (de) |
| GB (1) | GB1006137A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1560389A (en) | 1976-12-14 | 1980-02-06 | Degussa | Bascically substituted theophylline derivatives |
| DE3028272A1 (de) * | 1980-07-25 | 1982-02-25 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Durch purinbasen substituierte alkylamino-desoxy-1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1100642B (de) * | 1956-09-25 | 1961-03-02 | Chemiewerk Homburg | Verfahren zur Herstellung von basisch substituierten Alkylxanthin-derivaten |
| DE1123329B (de) * | 1958-10-18 | 1962-02-08 | Chemiewerk Homburg, Zweigniederlassung der Deutschen Gold- und Silber Scheideanstalt vormals Roessler, Frankfurt/M | Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten. |
| DE1124041B (de) * | 1959-06-10 | 1962-02-22 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung neuer Xanthinderivate |
-
1962
- 1962-03-30 DE DED38531A patent/DE1221641B/de active Pending
-
1963
- 1963-01-17 CH CH54863A patent/CH429739A/de unknown
- 1963-02-15 BR BR147019/63A patent/BR6347019D0/pt unknown
- 1963-03-11 GB GB9584/63A patent/GB1006137A/en not_active Expired
- 1963-03-28 BE BE630294A patent/BE630294A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR6347019D0 (pt) | 1973-07-19 |
| BE630294A (fr) | 1963-07-15 |
| DE1221641B (de) | 1966-07-28 |
| GB1006137A (en) | 1965-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH458394A (de) | Verfahren zur Herstellung von B-Amino-acylphenyl-Verbindungen | |
| CH436320A (de) | Verfahren zur Herstellung von Acylmelaminverbindungen | |
| CH445514A (de) | Verfahren zur Herstellung von 6-Alkylmorphinan-Derivaten | |
| CH426830A (de) | Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-derivaten | |
| CH430677A (de) | Verfahren zur Herstellung von p-Aminoarylaldehyden | |
| CH438350A (de) | Verfahren zur Herstellung von 6-Hydroxy-morphinan-Derivaten | |
| AT242863B (de) | Verfahren zur Herstellung von α-Amino-arylmethylpenicillinen | |
| CH415612A (de) | Verfahren zur Herstellung von 19-Nor-steroidverbindungen | |
| AT250582B (de) | Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden | |
| CH427812A (de) | Verfahren zur Herstellung von Oxathiazolinonen | |
| CH429729A (de) | Verfahren zur Herstellung von Aminoisoxazolen | |
| CH431511A (de) | Verfahren zur Herstellung von 1a-Alkylthio-3-keto-steroiden | |
| CH429739A (de) | Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten | |
| CH475985A (de) | Verfahren zur Herstellung von substituierten 2-Oxo-tetrahydrochinolinen | |
| CH418336A (de) | Verfahren zur Herstellung von Octahydrophenanthridinverbindungen | |
| AT241433B (de) | Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden | |
| CH460036A (de) | Verfahren zur Herstellung von Morphinan-Derivaten | |
| CH431518A (de) | Verfahren zur Herstellung von 16B-Niederalkylthio-17B-hydroxy-östren-3-onen | |
| CH475932A (de) | Verfahren zur Herstellung von Hydrindacenverbindungen | |
| AT242149B (de) | Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin | |
| AT257064B (de) | Verfahren zur Herstellung von 16α-Hydroxysteroiden | |
| CH450443A (de) | Verfahren zur Herstellung von Morphinan-Derivaten | |
| CH430735A (de) | Verfahren zur Herstellung von 2-Hydroxy-s-triazinen | |
| CH428750A (de) | Verfahren zur Herstellung von N-Trifluormethylaminen | |
| CH434277A (de) | Verfahren zur Herstellung von 3-Halogeno-4-nitro-6-alkylpyridazin-1-oxyden |